Recently, B. xylanisolvens has been demonstrated to be capable of boosting production of natural TFα sugar antigen-specific IgM antibodies in healthy humans, an antibody response believed to be involved in cancer immune surveillance [43]. This evidence concerns the gene CD40LG and cancer.